Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic

被引:0
|
作者
Paulo Eduardo Stanga
Francisco Javier Valentín-Bravo
Sebastian Eduardo Francis Stanga
Ursula Inge Reinstein
Salvador Pastor-Idoate
Susan M. Downes
机构
[1] The Retina Clinic London,
[2] UCL Institute of Ophthalmology,undefined
来源
Eye | 2023年 / 37卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3282 / 3289
页数:7
相关论文
共 50 条
  • [21] The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
    Butt, Thomas
    Lee, Aaron
    Lee, Cecilia
    Tufail, Adnan
    [J]. BMJ OPEN, 2015, 5 (05):
  • [22] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    [J]. Eye, 2023, 37 : 3574 - 3581
  • [23] Dynamics and patterns of recurrence in neovascular AMD during real-world management using automated fluid monitoring
    Prenner, Veronika
    Schmidt-Erfurth, Ursula
    Fuchs, Philipp
    Leingang, Oliver
    Coulibaly, Leonard Mana
    Bogunovic, Hrvoje
    Barthelmes, Daniel
    Reiter, Gregor Sebastian
    [J]. HELIYON, 2024, 10 (10)
  • [24] Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5
    Cho, Soo Chang
    Park, Kyu Hyung
    Park, Sang Jun
    Joo, Kwangsic
    Woo, Se Joon
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [25] REAL-WORLD TREATMENT PATTERNS AND VISUAL OUTCOMES IN THE FIRST 12 MONTHS OF FARICIMAB USE IN DME: UK FARWIDE-DME STUDY
    Kiire, C.
    Peto, T.
    Reynolds, R. R.
    Bailey, C. B.
    Downey, L. D.
    Pearce, I. P.
    Sivaprasad, S. S.
    James, N. J.
    Shah, N. S.
    Dayal, P. D.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (01) : 34 - 35
  • [26] Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Paris, Arianna
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [27] Real-world outcomes for fellow eyes in neovascular age-related macular degeneration
    Aydogmus, Fatma Sema Akkan
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Lasalle, Claudia
    Ramsey, David J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [28] Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands
    Verbraak, Frank D.
    Ponsioen, Dirk L.
    Tigchelaar-Besling, Odette A. M.
    Nguyen, Vuong
    Gillies, Mark C.
    Barthelmes, Daniel
    Klaver, Caroline C. W.
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E884 - E892
  • [29] Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study
    Aziz, Aamir
    Khanani, Arshad
    London, Nikolas
    Hagen, Molly
    Danzig, Carl
    Kulkarni, Amol
    Sheth, Veeral
    Jhaveri, Chirag
    Eichenbaum, David
    Singer, Michael
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [30] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    [J]. EYE, 2023, 37 (17) : 3574 - 3581